chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial and follow-up information has been received from a certified medical assistant, for the Pregnancy Registry for GARDASIL concerning a 19 year old female with a history of heart murmur and 1 previous pregnancy and 1 full term delivery who on 04-SEP-2007 was vaccinated intramuscularly with the first dose of GARDASIL during the first trimester of pregnancy. Concomitant therapy included prenatal vitamins and iron tablets. The patient sought unspecified medical attention in the physician's office. On 13-SEP-2007 routine ultrasound was performed and the result was normal. Follow-up information was received that during pregnancy, the patient developed papilloma viral infection and Chlamydia infection. On 27-January-2008, the patient was placed on ZITHROMAX, 1 gram, 1 dose for the treatment of Chlamydia infection. The outcome was unknown. During labor/delivery, the baby developed umbilical cord around neck. On 05-MAR-2008 the patient delivered a full-term, normal and healthy baby boy with no congenital anomalies. The weight of the baby was 7.4 pounds and the Apgar score was 9/9. Additional information is not expected.
This spontaneous report as received from a licensed practical nurse (LPN) refers to a patient of unknown age and gender. On 14-MAR-2013 the patient was vaccinated with the first dose of GARDASIL (Lot # not reported) (dose and route not reported). On 22-AUG-2013 the patient was vaccinated with the second dose of GARDASIL (Lot # 0692AA, exp date 13-AUG-2013) (dose and route not reported). Concomitant therapy was not reported. It was reported that on 22-AUG-2013 the patient received a second dose of GARDASIL that was expired (exp date. 13-AUG-2013). No adverse effect reported. Additional information has been requested.
Eleven days after vaccination a 1.5"x3" itchy, red, warm welt developed at the injection site and got bigger the next day by about half (that is today).
325PM c/o dizziness, pale, eyes rolled back & went limp eased to the floor & was verbally responsive immed;335PM BP 140/70, P92, R16 c/o weakness & didn't feel strong;c/o stiff neck could not move side to side;tightness in throat swelling;
Case number PHEH2017US001325, is an initial spontaneous report received from a pharmacist on 10 Jan 2017. This report refers to a 71 years old female patient. Medical history was not reported. Concomitant medication included PLAVIX. The patient was vaccinated with FLUAD (batch number: 165803, expiry date: Apr 2017) intramuscularly at a dose of 0.5 ml on 09 Dec 2016. On 10 Dec 2016 after vaccination, the patient experienced bruise (bruising of arm) and knot below deltoid on outer part of arm that the patient received the vaccine, it was reported that, could not tell if the events was at vaccination site. The bruising and knot lasted for one month, the knot was gone but bruise was slightly there still. The final outcome of the event bruise of arm was reported as condition improving and for event knot it was reported as complete recovery on 10 Jan 2017. The seriousness of the events was reported as non serious and causality was not reported.
very dizzy; headache at the back of the head; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 10-Mar-2021, the patient experienced DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head). At the time of the report, DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head) outcome was unknown.            Treatment details included aspirin, acetaminophen and caffeine.
Child was not supposed to get vaccine. Writer gave vaccine to wrong child. Discussed with pharmacist and PCP and have not concerns that he received it. Followed up with patient and family 8/30/2023 and child is doing fine.
pt recv vax & was instructed to remain in area for 15-30min;10:45 pt c/o swelling sensation in throat;pt did not immed appear to be in distress smiling;upon being seated became diaphoretic & trembling;epi;
Pt recvd 1st dose of Hep B vax on 29JAN92; 10 to 15 mins p/vax felt dizzy & fell to the floor-did not lose consciousness; exp chills, h/a, neck pain, t100.8; sx persisted for approx 1 1/2 days; No further details were provided;
Patient stated she has fever, excessive sweating, and vomiting since the day of vaccine 01/02/21; she was taking ibuprofen
Information has been received from a pharmacist concerning a 71 year old female patient with no allergies and no pertinent medical history who on 07-NOV-2010 was vaccinated with the 0.5 ml dose of PNEUMOVAX 23 (Lot# 665904/0866Z) (Exp 04-07-2011), IM. There was no concomitant medication. Pharmacist stated that on 07-NOV-2010 later the same night after the patient had received her first dose of PNEUMOVAX 23, experienced tingling and difficulty moving her arm. The patient called the pharmacist to state that she was a little better. There were no laboratories diagnostic studies performed. The patient sought unspecified medical attention. Additional information has been requested.
Not feeling good; Arm starts swollen, red, very red and hot; Arm starts swollen, red, very red/ cheek got red; Arm starts hot and it also affected the left side of patient face; cheeks like burning up; the cheek get flushed red and numb; the cheek get flushed red and numb; Eye feels like it does not want to stay open; It opens but it feel like it wants to close; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727) single dose for COVID-19 immunization on 27Mar2021. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on unknown date. The patient first shot was okay and second shot was on 27Mar2021 and now had these symptoms just today after shot which was on the Sunday (28Mar2021). The patient had some unpleasant reactions about a week. The patient arm started swollen, red, very red and hot and it also affected the left side of patient face. The patient cheek got red, and cheeks like burning up. The left side of patient face, the cheek got flushed red and numb. The eyes felt like it did not want to stay open and patient couldn't keep it open. It opened but it felt like it wanted to close. Right now, patient was not feeling good. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected
no sign or symptom reported; temperature excursion; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.      On 11-OCT-2021, a dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) suffered a temperature excursion with a temperature of  9.7 celsius degrees for 1 hour. There was no previous temperature excursion. On 29-OCT-2021, the patient was vaccinated with that dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB), lot # T026961 with expiration date: 02-APR-2023, as prophylaxis (strength, dose and route of administration were not administered). There were no signs or symptoms reported.
vaccine was expired (4 days), manufacture was notified, Moderna is evaluation the effectiveness of the expired vaccine and we are waiting for a response.
Pt recvd vax @ 3PM about 1-2mins later, lower legs, ankles & feet turned purplish-blue, face flushed; lower extremities & face hot to touch; had 1-2 mm red flat area on ankles w/fine flat rash on chest pinpoint splotches on bottoms of feet;
approx. 5 minutes after immunization was administered, patient was nodding off, sweating and unresponsive to rph's voice. 911 was called and patient became responsive. paramedics cleared him as okay
13:25: Pt in waiting room, came to counter and stated she didn't feel well.  Was very pale.  Stated having problems breathing.  13:26: Pt assisted to site down. MD notified immediately-crammed pt ordered Epipen auto inject O.3 mg given IM left thigh.  13:36: BP-156/120; 13:39: O2 @ 2L per made started per MD.  13:40 BP: 148/118, pulse oximetry 99% pulse 14.  13:50: Pt transported to ER by ambulance. The medical records received on 2/24/04 states dizziness and tight in throat.
Nose bleed- left nostril. After compression with tissue, blood stopped within seconds. On 07/21/2013, the right nostril began to spontaneously bleed. Again, it stopped almost immediately after compression was started.
About 13 days after it developed itchy rash from ankles to sides of torso. All the way up to clavicle shoulder blades both
Information has been received from a pharmacist referring to a 60 year old female patient with depression. The patient's medical history included headaches. The patient did not have drug reactions/allergies. On 10-SEP-2015 the patient was vaccinated a dose of with ZOSTAVAX (dose, route and lot # were not reported) and a dose of PREVNAR (dose, route and lot # were not reported) at the same location on the same arm. There was no concomitant therapy. Later that same day, the patient developed a rash that extended from the injection site area down to the patient's elbow. The patient went to see the pharmacist and a physician and was given an unspecified antibiotic (manufacturer unspecified). No lab diagnostics studies were performed. At the time of the report, the patient did not recover. Causality was not provided. Additional information has been requested.
Employee complained of feeling hot flashes, sudden body chill and numbness tingling sensation to his arm where the injection was given.  Blood pressure was elevated and employee says he has hypertension but its not usually that high.  Employee takes Lisinopril.
Pharyngeal swelling, urticaria, right arm swelling, required epinephrine, Steroids, Diphenhydramine.
Started with severe back ache and headache. I didn't think much about it until the next morning when i was brushing my teeth and started throwing up. My whole body was in intense pain and i had the chills. My head felt like i was hit with a hammer, the pain was so bad. Nausea lasted until about 3:30 pm that day. I literally couldn't get off the bed due to the weakness and dizziness. When the nausea settled i was able to drag myself out of bed where my joints and head were still in extreme pain. I stayed up a couple of hours took some advil and went back to bed. Got up this morning and except for a sore stomach and a slight headache, I am fine now.
The evening following administration of the second COVID-19 vaccine, I experienced pain in my left armpit and noticed a large amount of swelling in the lymph node area. Unaware this could be related to the vaccine, I made an appointment with urgent care. The pain was mostly gone the next day and was only experienced when pressure was placed in the area of swelling. I was seen the following day (1/13/21) and it was noted that the swelling was not attributed to an infection and I was sent to the breast imaging center to rule out a breast cancer diagnosis. At this visit it was ruled not to be cancer and was potentially attributed to the vaccine. I still have the englared armpit/lymph area, but no pain.
Pfizer 11/18/21, Moderna 2/22/21, 3/25/21. Positive on 1/2/23
Low grade fever, and slept for 36 hours without being able to wake up to eat.
2/23/06 9:30AM DTAP given left arm; 2/24/2006 Left arm, swollen, red, itchy, low grade temp-Mom applied ice and gave Benadryl
This case was reported by a nurse and described the occurrence of an injection site reaction in a 45 year old female pt who received hep B vaccine recombinant (Engerix). On 25Jun04, the pt received the first dose of Engerix B in the right arm (lot ENG5540A2). Immediately following the admin of Engerix B, on 25Jun04, the pt experienced an injection site reaction characterized as redness and swelling. The events resolved approx 40 minutes later on 25Jun04. The nurse considered the events to probably be related to vaccination with Engerix B.
The patient felt some lightheadedness and dizziness post vaccination. While talking with the patient he began to collapse in his chair. The pharmacist held the patient up in the chair while the event occurred. The patient came back to within about 30 seconds of the event starting and was unaware that he had lost consciousness for a short period of time. At this time he was given some water and a cool pack to rest on his neck. He was then given some orange juice. He began to feel better and moved himself from the vaccination room to a post-vaccination waiting chair in view of the pharmacy. He was able to walk under his own power to the chair and remained seated for the duration of his post-vaccination wait time. Upon completion of his wait time the patient left on his own and said that he was feeling well and able to go.
Syncope, loss of consciousness lasting about 5 secs,  projectile vomiting and sweating
11/2016 -  Injection pain at time of flu shot and progressive worse month to month after that.  4/2017 - 5 month post injection exam discovered limited range of rotator cuff and cortisone shot.  8/2017 - 10 month exam required MRI and confirmation of torn supraspinatis tendon in rotator cuff and bursa sac inflammation due to bursitis.
Widespread Maculopapular rash appeared from bilateral ankles to groin at 5:15pm. Patient complained of burning and itching. Benadryl 25mg po administered and hydrocortisone cream applied topically to rash. At 6:30pm, edema, warmth, and pain at injection site. Rash still present. Benadryl 25mg po administered again at 9:30pm. Rash receding but still present today, injection site still painful but edema resolved 10/17/2019.
2 inch area swollen and red at injection site; congestion, hoarseness, sore neck; red eyes, chills but no fever; achy; headache; fatigue.  Self treated with rest and Tylenol.  Checked with endocrinologist.
Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands; Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands), COVID-19 IMMUNISATION (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9237B) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands), COVID-19 IMMUNISATION (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands), COVID-19 IMMUNISATION (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands) and COVID-19 IMMUNISATION (Given Moderna brand instead of the Pfizer COVID vaccine on accident, not supposed to mix different brands).    No concomitant medication information was provided.  Reporter stated, they did not have the Pfizer LOT# because they did not get the Pfizer vaccine at office. Patient come in that had received the two dosage of the Pfizer covid vaccine of 6 month-4 years (maroon cap)outside of clinic. They came here for the third dose, which we did not have that dose in office but it was accident so, they received the dose of the Moderna 6 month-5 years as the third dose on accident.  Reporter stated, Well, the Pfizer for that age group was 3 dose series for under 4 so, they had not completed their primary series yet because they had two dosages because they are under age 4.  No treatment information was provided.
Pain, redness, pain thru arm and elbow, nausea, fatigue. 10/1/02 28 year old complains of redness and swelling on L arm after receiving Anthrax vaccine. Vaccine given on 29th of Sept and swelling began that night. Pt states dull pain goes halfway down the arm to the elbow. 8.1cm x 8cm area of erythema site of injection. Reaction to local administration of Anthrax. Tylenol, Motrin, heat.
It was reported that a 15 y.o. male PT received a TD adult vaccination administered on 1/7/02 at 10 a.m. At approximately 3:30 that same day the PT developed blotchy, itchy rash on his face. PT was given Benadryl 50 mg po. The PT's recovery status is unknown.
Pt. states that after receiving the 1st dose of Phizer 12/16/2021, started experiencing symptoms immediately went into Anaphylactic shock (throat swelling) and low O2. Transported to Emergency Room, treated with Epi-Pen x2, )2, IV Fluids, and Magnesium. Transported to Hospital for Overnight Observation. Discharged 12/17/2021 with Follow-Up recommendation Primary visit 12/20/2021. Primary wrote up Medical Exemption 01/05/2022.
rashes; skin itch; This is a spontaneous report from a Pfizer Sponsored Program.  A contactable consumer reported that a female patient (reporter's mother) of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date (lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter was calling on behalf of her mother's experience after taking the first dose of the COVID vaccine. The patient was scheduled for her second dose on 10Mar2021 but she has rashes and skin itch. The patient's doctor advised the patient not to take the second dose of the vaccine. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nose bleed; This is a spontaneous report from a contactable consumer or other non hcp.     A 76-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9261 and expiration date was not reported), via an unspecified route of administration in arm right on 28Jan2021 at 12:10 as single dose for covid-19 immunization. He had already set appointment for second dose. No further details provided. Medical history included diabetes mellitus from Mar2020 and ongoing. The patient's concomitant medications were not reported. The patient experienced nose bleed on 28Jan2021 13:00 with outcome of recovered. Patient just received the Covid-19 vaccine today about 10 minutes after 12. About 1pm today he started to get a nose bleed and it continued bleeding for about 40-50 minutes, but it has subsided and stopped. Thought he should call to inform Pfizer of this. No History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) and no Additional Vaccines Administered on Same Date of the Pfizer Suspect. No Prior Vaccinations within 4 weeks prior to the first administration date of the suspect vaccine. Pertinent Details was none and no Family history. The outcome of the event was recovered.  Follow-up attempts are completed. No further information is expected.
PT REPORTS SWELLING, PAIN, REDNESS @ RXN SITE - REC PT USE COLD PACKS, IBUPROFEN OR APAP, HYDROCORTISONE CRM, AND/OR ANTIHISTAMINE (NOT BENADRYL)-FILLED OUT VAERS - REC F/U W/ DR IF DOES NOT IMPROVE OR WORSENS
Information has been received from a nurse concerning a 3 year old boy with no pertinent medical history and no history of drug reactions or allergies who 2 years ago (in approximately March 2006), was vaccinated with one dose of VARIVAX (Oka/Merck) at another facility than the reporter's facility. There was no concomitant medication. On 20-MAR-2008 the patient developed widespread red lesions. The nurse stated the diagnosis may be possible chickenpox. No treatment has been recommended. As of 26-MAR-2008 the patient's chickenpox persisted. The patient's mother also mentioned her daughter received one dose of VARIVAX (Oka/Merck) in 2002 and developed "a few red bumps on her buttocks". (Refer to WAES# 0805USA01256.) No further information is available.
Severe muscle aches; Severe bone aches; Very strong reaction; This case was reported by a consumer and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included surgery (previous failed surgery).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced muscle pain, bone pain and back pain. The patient was treated with prednisone (Prednisone Dose Pack). On an unknown date, the outcome of the muscle pain, bone pain and back pain were recovered/resolved.   It was unknown if the reporter considered the muscle pain, bone pain and back pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. On 22nd September 2019, the patient just completed a 12 day Prednisone dose pack  and it just so happened that the patient's pharmacy called and said they had second dose of the vaccine available for the patient until 28th September 2019. The patient asked would it be better to put this off as the recent prednisone may make it so the patient did had an effective response to the vaccine. The patient asked that if so then how long should the patient wait. The prednisone was because of terrible back pain and the Magnetic resonance imaging showed so much that it was time the patient had to have surgery to do a fusion from a previous failed surgery.  The patient asked in regards to this would it be best to hold off until after surgery. The patient experienced very strong reaction the first time with 10 days of severe muscle and bone aches.